14 results
Antifungal Agents Frequently Used in Leukemia
Antibiogram:
 • Fluconazole
 • Itraconazole
 • Voriconazole
 • Posaconazole
 • Caspofungin
Antifungal Agents ... Frequently Used ... #antibiogram #pharmacology ... #management #oncology
Tranexamic Acid - Indications and Pharmacology
Pharmacokinetics:
 • MOA: Inhibits plasminogen activation to plasmin & inhibits fibrinolysis
Tranexamic Acid - Indications ... and Pharmacology ... arterial thrombotic events ... #Pharmacology # ... hematology
This is an overview of the 3 main drug classes used to treat Hepatitis C

The new
Hepatitis C The new agents ... recommendations change frequently ... ambcarerx #HCV #Medications ... Classes #DAAs #Pharmacology
Chronic Lymphocytic Leukemia (CLL) - Summary
Overview: 
 • Most common leukemia in adults
 • Disorder of
low-risk disease • Indications ... ) • Treatment Agents ... 1) Alkylating agents ... Lymphocytic #Leukemia #oncology ... #hematology #hemeonc
Atopic Dermatitis - Topical Treatment Options 
First Line: Topical Corticosteroids 
  - High Potency: Betamethasone
therapy is non-pharmacologic ... of the biologic agent ... Topical #Treatment #Medications ... #Pharmacology # ... Dermatology #Management
Cyclophosphamide Pharmacology Summary

Mechanism of Action: Alkylating Agent
Indications: Solid tumors, Breast. bladder, endometrial. ovarian, testicular, osteosarcoma
Toxicities -
Cyclophosphamide Pharmacology ... Action: Alkylating Agent ... Indications: Solid ... Cyclophosphamide #Pharmacology ... #oncology
Pharmaceutical agents other than olmesartan have been reported to cause villous atrophy on occasion and are
Pharmaceutical agents ... to be the most frequent ... several other agents ... #Pharmacology #Drugs ... #Induced #Medications
Aplastic Anemia - Overview

Who?
• M = F
• 3 peaks:	1) Childhood	2) 15-25 years	3) >60 years

What?
• Aplastic anemia
- Antithyroid medications ... salts • Chemical Agents ... Benzene • Physical Agents ... Aplastic #Anemia #oncology ... #hematology #diagnosis
Medications to Avoid in Patients with G6PD Deficiency Due to Risk of Hemolysis
 - Chloroquine (Aralen)*
Medications to Avoid ... - Antimalarial Agent ... Deficiency #Hemolysis #Medications ... Differential #Diagnosis #Pharmacology ... #Hematology
Checkpoint inhibitors and indications
Anti CTLA-4 antibody:
 • Ipilimumab: Malignant melanoma, Renal cell cancer
Anti-PD-1 antibody:
 • Nivolumab:
inhibitors and indications ... cancer with high-frequency ... cancers with high-frequency ... Checkpoint #inhibitors #indications ... #oncology #pharmacology